What is the efficacy and safety of transcatheter tricuspid valve-in-valve implantation for patients with inoperable tricuspid surgical prosthesis dysfunction? Thirty-day mortality after greatly effective transcatheter treatment is 2 times less than the estimated surgical risk.
Keywords: surgical heart valves; transcatheter heart valves; transcatheter intervention; tricuspid valve; valve-in-valve.
Copyright © 2024 Elsevier Inc. All rights reserved.